12-Month Lobbying Summary - Consultant

Details Regarding the Identified Subject Matter

Subject matters	Details	Categories
Economic Development, Health, Industry	Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a priority of the government	Policies or Program
Budget, Health, Industry	Engagement with federal officials regarding Health Canada’s plans for the implementation of a national strategy for rare diseases, the Canada Drug Agency, and Bill C-64, An Act respecting National Pharmacare	Policies or Program
Economic Development, Health, Industry, Research and Development	Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada	Policies or Program
Health, Industry	Engagement with officials regarding access and approval of mental health treatments and drugs.	Policies or Program
Budget, Health	Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.	Policies or Program
Budget, Health, Industry	Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board	Policies or Program, Regulation
Budget, Health, Industry, Research and Development	Implementation of the Biomanufacturing and Life Sciences Strategy	Policies or Program
Economic Development, Health, Industry, Intellectual Property, Research and Development, Science and Technology	Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.	Policies or Program

• Subject matter details in previous versions

  Details Regarding the Identified Subject Matter

  Subject matters	Details	Categories
  Economic Development, Health, Industry	Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan	Policies or Program

Government Institutions

• Finance Canada (FIN)
• Global Affairs Canada (GAC)
• Health Canada (HC)
• House of Commons
• Innovation, Science and Economic Development Canada (ISED)
• Patented Medicine Prices Review Board (PMPRB)
• Prime Minister's Office (PMO)
• Privy Council Office (PCO)
• Public Health Agency of Canada (PHAC)
• Senate of Canada
• Treasury Board Of Canada Secretariat (TBS)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

• Grass-roots communication
• Oral communication
• Written communication
• Arrange one or more meetings

WILLIAM DEMPSTER, Consultant (Business address and contact information)

Public offices held